Press Releases :: VolitionRx Ltd (VNRX)

Dec 17, 2012 • 6:30 AM EST Volition Launches NuQ® Epigenetic Immunoassays for Research Use

Aug 21, 2012 • 6:30 AM EDT VolitionRX to Begin Prospective Clinical Trial in Colon Cancer

Jul 16, 2012 • 6:30 AM EDT VolitionRX Issues CEO Letter to Shareholders

Jul 9, 2012 • 6:30 AM EDT VolitionRX Signs Collaboration Agreement With Stefan Holdenrieder of Rheinische Friedrich-Wilhelms-Universitat Bonn Germany

May 14, 2012 • 8:00 AM EDT VolitionRX Raises Over $1 Million To Begin Clinical Trials of Blood Based Diagnostic Tests

Mar 27, 2012 • 7:01 PM EDT Pioneering New Science Nucleosomics Advances Blood Based Diagnostics for Cancer

Feb 17, 2012 • 5:00 AM EST Volition Signs Collaboration Agreement With Abcodia

Dec 22, 2011 • 7:00 AM EST VolitionRX Limited Intellectual Property Update: New Patent Filed

Dec 9, 2011 • 9:00 AM EST VolitionRX Limited Issues 525,000 Shares to ValiRx; Final Requirement of Share Purchase Agreement

Oct 11, 2011 • 7:00 AM EDT Volition Ticker Symbol Changed to VNRX.OB; Name Change to VolitionRX Limited Completed